Everything you need to know about pain management: approaches, types, and advances

Pain, a universal and complex experience, represents a major public health challenge worldwide. In France, the National Institute of Health and Medical Research (Inserm) estimates that it is the cause of two-thirds of medical consultations. Even more alarming, no fewer than 12 million French people suffer from so-called "chronic" pain, that is, pain that persists for more than three months, responds poorly to conventional treatments, and significantly affects patients' quality of life, both personally and professionally. This phenomenon increases with age and is more prevalent in women.

Far from being a simple symptom, chronic pain becomes a disease in its own right when it persists over time, thus losing its function as a warning signal. Faced with this reality, researchers and healthcare professionals are making considerable efforts to better understand its mechanisms and, above all, to improve its management. This article aims to explore in depth the different facets of pain treatment, from its fundamental understanding to the most innovative therapeutic strategies.

Understanding pain: an essential step to better treat it

To understand pain treatment, it is imperative to grasp its nature. The International Association for the Study of Pain (IASP) defines it as "an unpleasant sensory and emotional experience associated with, or resembling, that associated with actual or potential tissue damage." This definition emphasizes its subjective and multidimensional nature, involving both physical sensations and emotions. There is not just one form of pain, but rather several types, each with distinct characteristics, although there may be complex overlaps in some patients. Sources primarily identify three categories of pain, classified according to their nature and duration: Nociceptive pain: This is directly related to the stimulation of nociceptors, specialized receptors activated by potentially damaging stimuli. These stimuli can be a blow, joint inflammation, or excessive heat. The information captured by nociceptors is transmitted via specific nerve pathways to the brain, where it is interpreted, particularly in the cerebral cortex. This type of pain is often described as a useful warning signal for etiological diagnosis. Neuropathic pain: Unlike nociceptive pain, this type of pain is caused by damage to nerve fibers or the central nervous system itself. It can occur, for example, during shingles (reactivation of the chickenpox virus), diabetes, or following an amputation. It is often described as burning, tingling, electric shock, numbness, or stabbing sensations. Even the slightest touch can cause unbearable pain, a phenomenon called allodynia or hyperalgesia, characteristic of this type of pain. It is sometimes misunderstood by patients and caregivers, and can even be located far from the nerve lesion itself. Nociplastic pain: This pain is sometimes similar to neuropathic pain, but it is often generalized throughout the body and is not associated with visible damage to nerve fibers. It is thought to be due to a dysfunction of the pain detection and control system itself, leading to an exaggeration of the nerve signal and/or an overinterpretation of this signal by the brain. Fibromyalgia, characterized by widespread and persistent pain, sensitivity to pressure, intense fatigue, and sleep disturbances, is an example. There are also genuine pains without visible lesions, often called dysfunctional pain.

Pain is a multidimensional syndrome and its functioning is complex. The brain plays a central role, as it is the brain that "controls" pain. Pain has three well-mapped components within the brain:

• The sensory-discriminative component: This allows us to localize the pain and assess its intensity. A dysfunction can lead to a generalization or spread of localized pain.
• The affective-emotional component: This determines the emotion associated with the pain. Excessive emotional intensity may necessitate investigation for an underlying anxiety or depressive state.
• The cognitive-behavioral component: Painful information is linked to anxiety and memorized, influencing future behavior. An overly strong component can lead to kinesiophobia (fear of movement).

The intensity of pain can be modulated by the context (family, work, social), emotions, and the level of anxiety and depression. The memory of past painful experiences can also reinforce its perception. It is important to note that there is not always a direct link between the severity of an injury and the intensity of the pain felt. Tests may be normal despite intense pain, either because the lesion is invisible (too small, early stage), or because the pain is multifactorial.

Pain assessment: the key to personalized care

Accurate pain assessment is a fundamental prerequisite for any effective care. The patient is the central figure in this assessment, because no one is better placed than them to describe their pain, quantify its intensity, and determine where and when it occurs. They are also the only one who can judge the effectiveness of treatments and their pain relief.

Unlike many medical conditions, there is no radiological or biological test that can objectively measure pain; there is no "pain marker." The assessment therefore relies on the patient's ability to communicate and describe their experience. For individuals able to express themselves, several self-assessment scales are used by healthcare professionals: The Visual Analog Scale (VAS): This is presented in the form of a ruler. The patient positions a cursor on a line ranging from "No pain" to "As bad as I can stand." The healthcare professional reads the corresponding value on a scale of 0 to 10. The Numerical Rating Scale (NRS): Simpler, it asks the patient to rate their pain from 0 (no pain) to 10 (as bad as I can stand). It is widely used because it does not require any support.

These scales (VAS, NRS, SVS) provide information on the overall intensity, but do not provide information on the causes or mechanisms of the pain. In case of discrepancy between what the patient expresses and what the caregiver observes, the professional must believe the patient and adjust the scale used, seeking to understand the difference. The challenge of assessment becomes more complex when the patient is unable to express themselves verbally, such as young children, elderly people with reduced autonomy, or people with multiple disabilities. In these situations, any change in behavior can be a sign of pain. Caregivers and family members must be particularly attentive to bodily and behavioral signals, such as moaning, grimacing, stiffness, agitation, protective gestures, withdrawal, food refusal, sleep disturbances, or irritability. Specific observation grids have been developed for these populations, allowing them to identify these signals and assess the intensity of the pain. Among them are:

• For children: the EDIN, HEDEN, EVENDOL scales, the face scale, the vertical EVA, the San Salvadour grid (or DESS), the modified FLACC scale (from birth to 18 years). There is also a pediatric DN4 scale for neuropathic pain.
• For elderly and/or non-communicative individuals: the Doloplus2® scale, the Algoplus® scale, the Behavioral Scale for Elderly People (ECPA).
• For adolescents and adults with multiple disabilities: the EDAAP (Evaluation of Pain Expression in Adolescents or Adults with Multiple Disabilities), the EDD (Evaluation of Pain Expression in People with Communication Difficulties), the GED-DI (Pain Assessment Grid – Intellectual Disability), the ESDDA (Simplified Pain Assessment Scale for People with Communication Difficulties and Autism Spectrum Disorder).

Communication is essential. Healthcare professionals must systematically inform the patient about the treatment to be performed and the analgesia methods used. Pain caused by care is predictable and must be systematically prevented and treated, as it can lead to anxiety, exhaustion, and even refusal of care.

Drug treatments Pain management

The pharmacological management of pain (see our article on Nefopam) is tailored to its origin, intensity, duration, and location. The practitioner chooses the treatment modalities according to the type of pain (chronic, post-operative, related to care, migraine, etc.), following best practice guidelines. The objective is to counteract the pain mechanism and act according to its characteristics, favoring well-tolerated medications and taking into account the patient's medical history.

Conventional analgesics are the first-line treatment for nociceptive pain, whether acute or chronic. They come in different pharmacological classes, ranging from the mildest to the most potent:

• Paracetamol.
• Certain non-steroidal anti-inflammatory drugs (NSAIDs).
• Opioids, which can be weak or potent.

Opioids constitute a major class of analgesics. They act by mimicking the action of endogenous opioids (endomorphin or endorphin) produced naturally by the body, primarily in the central (brain and spinal cord) and peripheral nervous systems. We distinguish between:

• Weak opioids (Step 2):: codeine, dihydrocodeine, tramadol, opium. They are prescribed for moderate nociceptive pain, either as a first-line treatment or when Step 1 analgesics have failed.
• Strong opioids (Step 3):: alfentanil, fentanyl, hydromorphone, morphine, oxycodone, pethidine, sufentanil, tapentadol. Morphine is the first-line strong opioid for cancer pain. They are recommended for intense, acute, subacute (surgery, emergencies), persistent, or recurrent nociceptive pain (cancer), and in certain specific situations when first-line treatments have failed. Titration is an essential method for rapidly adjusting the dosage of an opioid, often performed in the recovery room for postoperative pain. Opioids can be administered via various routes: intravenous, subcutaneous, or oral. For continuous pain, a maintenance (daily) treatment is necessary, supplemented by immediate-release (inter-dose) medications for transient pain attacks. Opioids, like all medications, can cause side effects, the most common being constipation (almost inevitable with chronic use and requiring preventative measures from the first dose) and drowsiness (which usually decreases after a few days of titration). Other effects such as nausea, vomiting, sweating, nightmares, impaired attention, concentration, and memory, hallucinations, and myoclonus (involuntary muscle twitching) may occur. In cases of persistent side effects or ineffectiveness, opioid rotation is possible. It is important to emphasize that opioids are not always indicated for all types of pain. They are of little or no effectiveness on neuropathic pain and should not be used for primary headaches (including migraines) or nociplastic pain (fibromyalgia). The fear of morphine addiction is a misconception; its use post-operatively or for its analgesic effect does not create drug addiction or dependence. Discontinuation of strong opioid treatment should always be done under medical supervision, with a gradual reduction in dosage. In addition to conventional analgesics, doctors may use other molecules that have an analgesic effect even if that is not their primary purpose, particularly for chronic neuropathic pain. This is the case with certain antidepressants or antiepileptics, which act specifically on the mechanisms of this pain. It is important to note that prescribing these medications in this context does not mean that the patient is considered depressed or epileptic. Unfortunately, they are only effective in one out of two patients. Local pharmacological treatments also exist for chronic pain. These include, for example, lidocaine plasters (a local anesthetic) or capsaicin patches. Botulinum toxin injections can also be used for certain localized neuropathic pains, with an effect lasting several months. Combining medications with complementary actions can maximize effectiveness while limiting side effects (e.g., paracetamol or an NSAID with an opioid). It is generally not recommended to combine medications from the same class to avoid overdoses. Regarding the route of administration, the common belief that injection is more effective than oral administration is often false; The oral route is often comparable in effectiveness and avoids the painful procedure of injection. In cases of persistent pain despite treatment, several situations may be possible: the pain mechanism no longer corresponds to the drug's mode of action, the dose, route, or frequency of administration is inadequate, or there is variability in individual response. Medical monitoring is essential to adjust the treatment. It is recommended to take analgesics before the pain becomes too severe, as persistent acute pain can perpetuate itself and become chronic. Analgesics do not interfere with examinations, and it is even recommended to treat pain as a priority to allow examinations to be performed under optimal conditions. Non-pharmacological approaches: an essential dimension. Beyond medication, numerous non-pharmacological techniques play a key role in pain management, particularly for chronic pain. They are complementary to drug-based approaches and can be very useful. In some cases, for chronic pain, the role of medication can even be very limited (less than 30%) in overall management.These approaches fall into several categories:
  1. Physical approaches:
     • Massage therapy.
     • Physiotherapy, including the application of heat, cold, or electrical current.
     • Balneotherapy.
     • Supportive devices (corset, foam collar, strapping).
     • Postural and movement education.
     • Reconditioning to exertion and functional restoration of the spine, particularly for chronic lower back pain. Strict rest is no longer considered a useful strategy for chronic lower back pain.
  2. Electrical or magnetic stimulation:
     • Transcutaneous electrical nerve stimulation (TENS): Electrodes temporarily attached to the skin deliver a low-intensity current to relieve pain. It works by "closing" the door to pain transmission in the nervous system and/or by stimulating the production of endogenous analgesics (naturally produced by the body). A test session is necessary to adjust the settings, and the device is used regularly by the patient.
     • Spinal cord electrical stimulation: More invasive, it involves implanting electrodes in the spinal column to inhibit the transmission of pain signals.
     • Repetitive transcranial magnetic stimulation (rTMS): Very promising, it involves applying a powerful magnetic current to the scalp to modify the electrical activity of brain areas involved in pain control. Recent studies have explored its use to identify patients who could benefit from it, particularly for neuropathic pain.
  3. Mind-body methods: These methods address the person in their physical and psychological dimensions, helping them to mobilize their own resources. They counteract situations of muscular and emotional tension linked to pain and stress, and can break the vicious cycle of pain-tension-stress. They are complementary to medication and include: relaxation, hypnosis (or hypnoanalgesia) for pain relief, sophrology, and meditation. These techniques often require training to enable independent use (self-relaxation, self-hypnosis). When practiced by specifically trained professionals, they are ethical and safe. They can be effective for a wide range of situations and types of pain, with varying degrees of effect.

Non-pharmacological management is particularly relevant for specific populations:

• For children, methods such as sucrose or breastfeeding for newborns, distraction, and hypnoanalgesia are fundamental for preventing pain related to care. Learning mind-body techniques (relaxation, biofeedback, hypnosis) is an effective long-term treatment for migraines in children.
• For elderly and multi-disabled individuals who are non-communicative, special precautions are necessary before any painful procedure. In addition to local anesthetics and MEOPA (equimolar mixture of oxygen and nitrous oxide), non-pharmacological methods such as choosing the right location, having a loved one present, using toys or familiar objects, music, and simply talking are essential.

The Placebo Effect and the Therapeutic Relationship

The placebo effect is a fascinating and increasingly studied dimension of pain management. A placebo is a substance (or any other means, such as surgery or the action of the therapist themselves) that appears to treat a health problem, although it lacks any demonstrated pharmacological or specific effect on that problem. The placebo effect, meanwhile, is the non-specific efficacy that is added to the scientifically proven efficacy of any drug or therapeutic procedure, thus increasing the "total" efficacy of the treatment.

How does this effect work? Several mechanisms are associated with its effectiveness:

• The relationship of trust: Establishing a bond of trust between the healthcare provider (the one who prescribes or administers) and the patient (the one who receives) is fundamental.
• The patient's expectation and belief: The greater the patient's expectation and the stronger their belief in the treatment, the greater the treatment's effectiveness (and therefore the placebo effect) will be.
• The healthcare provider's conviction: The physician's enthusiasm and conviction for a treatment can also enhance this effect.
• Cognitive and emotional mechanisms: Clear explanations, reassurance, and a supportive attitude from the healthcare provider contribute not only to trust but also to a reduction in anxiety, which is a major factor in the placebo effect.
• Neurobiological Mechanisms: Pain relief by a placebo is underpinned by neurobiological mechanisms of the same nature as the specific effect of an analgesic, notably involving the activation of the body's endogenous opioid systems.

The placebo effect is not limited to analgesic medications; it contributes to the effectiveness of all medications. From an ethical standpoint, in the context of clinical trials, the use of a placebo must be accompanied by the possibility of prescribing rescue analgesics if the pain level reaches a predefined threshold.

To maximize the effectiveness of a treatment, it is desirable to capitalize on the placebo effect. This involves developing a good relationship of trust between patients and caregivers, known as the therapeutic alliance. This alliance is one of the essential components of successful treatment, along with the accuracy of the information provided and the resulting trust. When the patient understands and accepts how the medication works, they expect noticeable relief, which enhances overall effectiveness.

Psychology and Pain: A Complex Interaction

The question of whether pain is "all in your head" is common. According to the IASP definition, pain is an unpleasant experience, both sensory and emotional. This means that it is experienced simultaneously on a physical and psychological level, regardless of its origin. Therefore, there is no physical pain without a psychological counterpart, and conversely, no psychological disorder without a physical correlation. Sometimes, the pain felt in the body can be the unconscious expression of an underlying psychological difficulty (trauma, grief, separation). However, it is essential to emphasize that treating chronic pain exclusively with psychotherapy is pointless. On the contrary, a multidisciplinary approach is indispensable, and the psychologist makes a valuable contribution to the diagnosis. The psychological state strongly influences the perception of pain. Pain is more difficult to bear in the presence of anxiety or depression, which are aggravating factors that must be identified and addressed. Chronic pain can cause depressive disorders through exhaustion, and conversely, a depressive illness can manifest primarily as pain. The symptoms of depression and chronic pain are often similar: fatigue, nervousness, loss of appetite, sleep disturbances, and loss of pleasure. Chronic anxiety, especially in the form of attacks, also manifests with various painful physical symptoms. Post-traumatic stress can develop into intractable pain requiring specific and comprehensive management. The patient's lifestyle can also influence pain. It is often a vicious cycle: lack of sleep worsens pain, and pain disrupts sleep; poor diet can influence the pain experience; overactivity may seem to distract from the pain but exhausts the body and intensifies it. Comprehensive management must therefore address lifestyle and consider lifestyle adjustments. Unfortunately, it is common for pain whose cause is not immediately identified to be labeled "psychosomatic." Sources emphasize that this term is a "catch-all" word, often used as a default diagnosis, unnecessary and even stigmatizing. An absence of an organic explanation in no way means that the patient is "crazy"; health sciences are not absolute knowledge, and a complex situation can be difficult to grasp in all its aspects. The goal is rather to adopt a therapeutic approach that integrates the dialogue between body and mind, essential in pain management.

When pain becomes unbearable and prevents one from living, it is essential to seek help. A multidisciplinary team can help rethink daily activities, to sort through what can be adapted, maintained, or given up. The experience of pain permanently alters self-perception, abilities, and relationships with those around them; la vie ne sera jamais "comme avant", mais cette expérience peut être une leçon de vie qui change le rapport à l'existence. Dans les cas extrêmes où la douleur est insupportable et mène à des idées suicidaires, il est vital de se rapprocher d'une personne de confiance ou d'un professionnel de santé pour chercher des solutions.

Prise en charge spécialisée et multidisciplinaire : les structures de la douleur chronique (SDC)

Face à une douleur qui persiste longtemps, qui est complexe et pour laquelle le patient se sent incompris, le médecin traitant reste le premier interlocuteur. Après plusieurs consultations et tentatives pour trouver des moyens efficaces, il peut orienter le patient vers un spécialiste. Cependant, dans certaines situations complexes, une orientation vers une Structure Spécialisée Douleur Chronique (SDC) sera proposée.

Les SDC sont des structures de soins identifiées et spécialisées dans la prise en charge de la douleur chronique. Elles répondent à un cahier des charges précis et sont labellisées par les Agences Régionales de Santé (ARS), avec un renouvellement quinquennal de cette labellisation. Elles regroupent des professionnels de santé de différentes disciplines (médecins, infirmiers, psychologues, etc.) experts dans l'évaluation et le traitement de la douleur.

Pour obtenir un rendez-vous en SDC, il est généralement nécessaire d'en discuter au préalable avec son médecin traitant ou un spécialiste, qui évaluera la pertinence de cette orientation. Le patient devra souvent remplir un questionnaire d'orientation et le renvoyer avec une lettre introductive de son médecin. Les adresses des SDC sont disponibles via un annuaire du ministère de la Santé ou auprès des ARS.

Le fonctionnement d'une SDC est basé sur une prise en charge individualisée. Une première évaluation, qui peut s'étendre sur plusieurs consultations de longue durée, est effectuée. Cette évaluation est fondamentale pour réaliser un bilan bio-psycho-social exhaustif, qui prend en compte les dimensions biologique, psychologique et sociale de la douleur. Ce bilan permet ensuite d'élaborer un projet thérapeutique personnalisé, discuté avec le patient.

Ce projet peut inclure diverses modalités de traitement:

• Traitements médicamenteux.
• Approches non médicamenteuses (hypnose, relaxation, neurostimulation transcutanée, etc.).
• Suivi psychologique.
• Des examens et gestes techniques spécifiques.
• Parfois, une hospitalisation de courte durée ou une orientation vers une autre structure plus spécialisée.

La rencontre avec des professionnels comme un psychologue, un psychiatre ou une assistante sociale, qui peut surprendre au premier abord, est justifiée par le fait que la douleur chronique a des retentissements sur l'ensemble de la vie quotidienne. Elle peut entraîner une souffrance morale, des difficultés socioprofessionnelles et financières, un impact sur la qualité de vie et les relations, qui à leur tour amplifient la douleur. L'objectif est de prendre en compte toutes ces conséquences et de mettre en œuvre des solutions pour les atténuer. Le médecin traitant reste un acteur clé, informé régulièrement de l'évolution du patient.

Dans ce parcours, le patient est activement informé des modalités du projet thérapeutique afin qu'il puisse rester acteur de sa prise en charge. Il est encouragé à développer des comportements adaptés au quotidien, à comprendre sa maladie et ses traitements, à observer ses propres réactions pour mieux gérer les crises, et à respecter les prescriptions et conseils des professionnels. L'acceptation de l'aide et l'adaptation des activités physiques, professionnelles, familiales et sociales sont essentielles pour améliorer la qualité de vie.

Pour s'informer, les patients sont invités à se tourner vers des ressources fiables : professionnels de santé, associations agréées (comme France Assos Santé), et sites internet de référence tels que la Société Française d'Étude et de Traitement de la Douleur (SFETD), le Centre National Ressources Douleur (CNRD), ou la Haute Autorité de Santé (HAS). L'éducation thérapeutique du patient (ETP) est également un levier majeur, avec des programmes validés et gratuits qui aident le patient à devenir plus autonome dans la gestion de sa douleur.

Les droits des patients et les avancées de la recherche

La prise en charge de la douleur n'est pas seulement une question médicale, c'est aussi un droit fondamental du patient, inscrit dans la loi française. L'Article L.1110-5 du Code de la Santé Publique stipule que "Toute personne a, compte tenu de son état de santé et de l’urgence des interventions que celui-ci requiert, le droit de recevoir, sur l’ensemble du territoire, les traitements et les soins les plus appropriés et de bénéficier des thérapeutiques dont l’efficacité est reconnue et qui garantissent la meilleure sécurité sanitaire et le meilleur apaisement possible de la souffrance au regard des connaissances médicales avérées". Des lois plus spécifiques, comme celle de 1999 sur l'accès aux soins palliatifs et celles de 2005 et 2016 sur les droits des malades et la fin de vie, renforcent ce droit.

Les professionnels de santé ont également des obligations légales en matière de douleur :

• L'infirmier a pour objet de "participer à la prévention, à l’évaluation et au soulagement de la douleur et de la détresse physique et psychique des personnes".
• Le médecin "doit s’efforcer de soulager les souffrances du malade par des moyens appropriés à son état et l’assister moralement".

Le droit des patients inclut également l'éducation thérapeutique. La loi Hôpital Santé Territoires de 2009 et l'arrêté de 2015 encadrent les programmes d'ETP, visant à rendre le patient plus autonome en facilitant son adhésion aux traitements et en améliorant sa qualité de vie. L'accès à ces programmes est volontaire, libre et gratuit.

Parallèlement à ce cadre légal, la recherche en matière de douleur est particulièrement active et a considérablement progressé ces dernières années. Ces avancées sont essentielles pour affiner les traitements et offrir de nouvelles perspectives aux patients:

• Variations génétiques : On sait aujourd'hui que des variations génétiques expliquent la différence de réponse d'un patient à l'autre pour un même analgésique, ainsi que l'apparition d'effets indésirables. Par exemple, des variations du gène COMT, impliqué dans la sécrétion de dopamine, pourraient être liées à un risque accru de chronicisation de la douleur.
• Nouveaux acteurs de la douleur : Les scientifiques ont identifié de nouvelles molécules et cellules impliquées dans les mécanismes de la douleur. Le système immunitaire, les troubles métaboliques et le microbiote intestinal joueraient également un rôle dans la chronicisation de la douleur.
• Imagerie cérébrale : Les recherches en imagerie médicale ont connu un essor, permettant de visualiser et même de quantifier la douleur, et de comprendre les modifications structurelles et fonctionnelles du cerveau dans les zones qui traitent l'information douloureuse en cas de douleur chronique.
• Compréhension des types de douleurs : La connaissance des différents types de douleurs s'est affinée, chaque type étant transmis par des voies nerveuses distinctes.
• Découvertes fondamentales : En 2021, le prix Nobel de médecine a récompensé la découverte des canaux TRP et PIEZO, impliqués respectivement dans les nocicepteurs thermiques et mécaniques, ouvrant de nouvelles pistes pour la recherche d'antalgiques.
• Protéines prometteuses : L'équipe d'Aziz Moqrich a découvert la protéine TAFA4, montrant chez les rongeurs une action puissante contre les douleurs inflammatoires, neuropathiques et post-opératoires, avec une durée d'action plus longue que les antidouleurs classiques comme les opioïdes. Cette protéine aurait également un effet réparateur sur les tissus lésés, ce qui pourrait prévenir la douleur chronique. Un essai clinique de phase I chez l'homme est espéré prochainement.
• Cibles thérapeutiques : Des nouvelles cibles thérapeutiques pour la douleur chronique inflammatoire sont identifiées.

Bien que des progrès significatifs aient été réalisés, des recherches intenses sont encore nécessaires pour améliorer la prise en charge des douleurs chroniques et inflammatoires, dont les mécanismes sont complexes et variables d'un patient à l'autre.

En conclusion, le traitement de la douleur est un domaine en constante évolution, nécessitant une approche holistique et multidisciplinaire. Comprendre la douleur dans toutes ses dimensions – sensorielle, émotionnelle, cognitive, et comportementale – est la première étape vers un soulagement efficace. L'arsenal thérapeutique combine aujourd'hui des médicaments de plus en plus ciblés et des approches non pharmacologiques variées, le tout encadré par une évaluation rigoureuse et une relation de confiance entre le patient et son équipe soignante. Les structures spécialisées dans la douleur chronique jouent un rôle important pour les cas complexes, tandis que la recherche fondamentale continue d'ouvrir la voie à des traitements encore plus innovants. L'objectif ultime est d'apaiser les souffrances et de garantir que personne ne reste seul face à sa douleur.

‍